SRZN (Surrozen) Company Net Income

SRZN (Surrozen) - company brandmark

Surrozen, Inc. generates revenue through the implementation of regenerative methods for gut and liver restoration. The company's net profit on this chart reflects earnings dynamics, where -0.35 represents the current level of the indicator. The struggle for biotech leadership and the risk of more efficient gene technologies emerging create pressure, while strict FDA oversight and venture capital drive the industry's development.

SRZN: Surrozen Inc. Company Net Income 07/04/2022 - 10/31/2026

Analytical breakdowns and data insights for company Surrozen (SRZN)

- price and consensus price forecast:
Stock Quotes Surrozen Inc.|SRZN - Analyst Consensus Forecast
- business market valuation indicators:
Market Value Surrozen Inc.|SRZN - Total Company Value
- balance sheet equity data:
Net Assets per Single Share Surrozen|SRZN - Company Book Value|Market Value to Book Value Ratio surrozen.com|SRZN - Aggregate Company Assets
- debt and liquidity details:
Total Debt to Capital Coefficient Surrozen, Inc.|SRZN - Long-Term Debt to Equity|Short-Term Debt to Capital Coefficient Surrozen Inc|SRZN - Company Total Debt|Debts to Book Capitalization Surrozen Inc.|SRZN - Company Long-Term Debt|Company Short-Term Loans and Borrowings Surrozen|Intermediate Coverage Ratio surrozen.com
- earnings and valuation multiples information:
SRZN - Company Net Income
Summary company analysis:Surrozen, Inc.
Mass-produced product of Surrozen Corp

This real-time indicator aggregates operating flows, transforming accounting data into projected net income to assess the current market value of the business. For Surrozen, Inc. (SRZN), such a metric reflects the cost efficiency of regenerative research under the leadership of Craig Parker, allowing the enterprise profit level to balance institutional risk against the asset's return potential.

Main competitors

Net Income Mesoblast Pharma|LCTX (Lineage Cell Therapeutics) - Net Profit|Company Net Income Cryo-Cell International Inc CCEL|Company Net Income FibroBiologics, Inc. (FBLG)|Company Net Income LGVN (Longeveron Inc)|Company Net Income BioRestorative Therapies, Inc. BRTX|Creative Medical Technology Holdings, Inc. - Company Net Income